NP Inc.

A291230

KR7291230001

Advertising & Marketing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
2,645 ^KRW	-2.04%		-0.19%	-18.62%

Apr. 03	Ultra Lithium Provides Bi-Weekly Default Status Report	MT
Mar. 29	Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	MT

An Unknown buyer agreed to acquire 8.999% stake in NP Inc. from Wysiwyg Studios Co., Ltd. for KRW 30.7 billion.

February 14, 2023

An Unknown buyer agreed to acquire 8.999% stake in NP Inc. (KOSDAQ:A291230) from Wysiwyg Studios Co., Ltd. (KOSDAQ:A299900) for KRW 30.7 billion on February 15, 2023. Transaction is expected to close on February 16, 2023.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	NP INC.	2,645 KRW	-2.04%	-0.19%	84.71M
	WYSIWYG STUDIOS CO., LTD.	2,050 KRW	0.00%	-1.44%	252M

Latest news about NP Inc.

Ultra Lithium Provides Bi-Weekly Default Status Report	Apr. 03	MT
Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10%	Mar. 29	MT
Algernon Pharmaceuticals Says Acquisition of Ifenprodil Program Completed by US Company	Mar. 27	MT
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	Mar. 07	MT
MCF Energy Acquired "Accretive" Czech Gas Projects With "Immediate Production And Growth Potential"	Feb. 26	MT
MCF Energy Acquires Accretive Czech Gas Projects with Immediate Production and Growth Potential	Feb. 26	MT
Vizsla Silver Up 0.75% In US Premarket After Reporting Additional High Grade Intercepts at La Luisa	Feb. 13	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD	Jan. 31	MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast	Nov. 30	MT
Algernon Pharma in LOI For Acquisition of its Chronic Cough Research Program For US$2 Million and 20% Equity Stake	Nov. 22	MT
Aehr Test Systems Receives Initial Order From Unnamed New Customer for Wafer Level Test, Burn-in Systems	23-09-18	MT
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH	23-09-06	MT
Novelplus Technology Trims Loss in H1	23-08-15	MT
Napo Pharmaceuticals Submits Funding Application to BARDA for NP-300 Development	23-08-09	MT
Moody's Withdraws Ratings on Austria's Addiko Bank	23-08-09	MT
Algernon Pharmaceuticals Engage Maxim Group to Explore Spin-Off of Ifenprodil Phase 2 Chronic Cough Drug Development Program	23-06-27	MT
Algernon Pharmaceuticals Receives Notice of Allowance From Japanese Patent Office for Repirinast and Treatment of CKD	23-05-31	MT
Vizsla Silver Up More Than 6% In US Pre-Market On Extending High Grade Mineralization at La Luisa and Defining New Exploration Targe to the North	23-05-30	MT
NP Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Former UN chief Ban returns to Myanmar, meets ruling general	23-04-24	RE
Titan Medical Announcing Receipt of MCTO	23-04-04	MT
Keppel Philippines Properties Divesting 50% Stake in SM Keppel Land	23-03-26	MT
An Unknown buyer agreed to acquire 8.999% stake in NP Inc. from Wysiwyg Studios Co., Ltd. for KRW 30.7 billion.	23-02-14	CI
Algernon Pharmaceuticals Announces Plans for a 180 Patient Phase 2b Chronic Cough Study of Ifenprodil	23-01-09	MT
BeLive Technology Announces Partnership with NP Inc. to Offer Extended Reality Commerce	23-01-09	CI

Chart NP Inc.

Duration

Period

More charts

Company Profile

NP Inc, formerly Samsung Special Purpose Acquisition 2 Co Ltd is a Korea-based company mainly engaged in the advertising content planning and production business. The Company operates its business through six segments. The Offline Brand Experience (BE) segment operates offline advertising content planning and production business. The Online BE segment operates online advertising content planning and production business. The Extended Reality (XR) Content segment is engaged in the planning and producing immersive content. The Performance Planning segment is engaged in the planning and production of performances. The Rental Business segment is engaged in studio rental business. The Other segment is engaged in leasing of idle facilities, among others.

Sector

Advertising & Marketing

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advertising & Marketing

	1st Jan change	Capi.
NP INC.	-18.62%	84.71M
PUBLICIS GROUPE SA	+24.29%	27.88B
OMNICOM GROUP., INC.	+10.84%	18.78B
FOCUS MEDIA INFORMATION TECHNOLOGY CO., LTD.	+8.39%	13.65B
THE INTERPUBLIC GROUP OF COMPANIES, INC.	-3.58%	11.88B
WPP PLC	+7.89%	10.86B
JCDECAUX SE	+7.47%	4.45B
PEOPLE.CN CO., LTD	-12.44%	3.74B
HAKUHODO DY HOLDINGS INC	+35.03%	3.4B
CYBERAGENT, INC.	+16.26%	3.31B

Other Advertising & Marketing

NP Inc.

Equities

A291230

KR7291230001

Advertising & Marketing

An Unknown buyer agreed to acquire 8.999% stake in NP Inc. from Wysiwyg Studios Co., Ltd. for KRW 30.7 billion.

Stocks mentioned in the article

Latest news about NP Inc.

Chart NP Inc.

Company Profile

Income Statement Evolution

Sector Other Advertising & Marketing